SLAS Honors 2014 Journal Achievement Award Winners

The Journal of Biomolecular Screening (JBS) and the Journal of Laboratory Automation (JALA), both published by the Society of Laboratory Automation and Screening (SLAS) in partnership with SAGE Publications, hosted a special reception to celebrate the 2014 SLAS Journal Achievement Award honorees on Jan. 20 at SLAS2014, the Third Annual SLAS Annual Conference and Exhibition, Jan.18-22, 2014, in San Diego, Calif.

JBS Editor-in-Chief Robert M. Campbell, Ph.D., of Eli Lilly and Company, Indianapolis, Ind., and JALA Editor-in-Chief Dean Ho, Ph.D., of the University of California, Los Angeles, announced honorees in three categories, all of which are freely available (open access) at JBS Online ( or JALA Online (

2014 SLAS Readers Choice Awards

Reflecting popularity among readers throughout 2013.

2014 JALA Readers Choice Award

A Review of Electronic Laboratory Notebooks Available in the Market Today By Michael Rubacha, Anil Rattan and Stephen Hosselet From JALA Volume 16, Issue 1, Pages 90-98

2014 JBS Readers Choice Award

Epigenetic Drug Discovery: Targeting DNA Methyltransferases By Jason M. Foulks, K. Mark Parnell, Rebecca N. Nix, Suzanna Chau, Krzysztof Swierczek, Michael Saunders, Kevin Wright, Thomas F. Hendrickson, Koc-Kan Ho, Michael V. McCullar and Steven B. Kanner From JBS Volume 17, Issue 1, Pages 2-17

2014 SLAS Authors Choice Awards

Reflecting popularity among authors (citations) throughout 2013.

2014 JALA Authors Choice Awards (tie)

Automation of Three-Dimensional Cell Culture in Arrayed Microfluidic Devices By Sara Montanez-Sauri, Kyung Eun Sung, John P. Puccinelli, Carolyn Pehlke and David J. Beebe From JALA Volume 16, Issue 3, Pages 171-185

Functional Cardiotoxicity Profiling and Screening Using the xCELLigence RTCA Cardio System By Biao Xi, Tianxing Wang, Nan Li, Wei Ouyang, William Zhang, Jieying Wu, Xiao Xu, Xiaobo Wang and Yama A. Abassi From JALA Volume 16, Issue 6, Pages 415-421

2014 JBS Authors Choice Award

Sirtuin 1 (SIRT1): The Misunderstood HDAC By Walter Stuenkel and Robert M. Campbell From JBS Volume 16, Issue 10, Pages 1153-1169

2014 JBS Reviewer Excellence Awards

Reflecting review quality, timeliness and volunteer service to JBS in 2013.

Christophe Antczak of Memorial Sloan-Kettering Cancer Center, New York, NY Len Pagliaro of Siva Therapeutics, Boulder, CO Serene Josiah of Shire Pharmaceuticals, Lexington, MA Charles Lunn of IonField Systems, Hillsborough, NJ

Now in their 19th years of peer-reviewed publication, the Journal of Biomolecular Screening (JBS) publishes 10 issues per year and has an impact factor of 2.207; and the Journal of Laboratory Automation (JALA) publishes six issues per year and has an impact factor of 1.457. Both journals are published by SLAS in partnership with SAGE Publications. For more information about SLAS, JALA and JBS, please visit


The Society for Laboratory Automation and Screening (SLAS) is an international community of more than 15,000 individual scientists, engineers, researchers, technologists and others from academic, government and commercial laboratories. The SLAS mission is to be the preeminent global organization providing forums for education and information exchange and to encourage the study of, and improve the practice of laboratory science and technology. For more information, visit

SLAS publishes two internationally recognized, MEDLINE-indexed journals. The Journal of Laboratory Automation (JALA) and Journal of Biomolecular Screening (JBS) uniquely serve laboratory science and technology professionals who work primarily in life science R&D. Together, JALA and JBS address the full spectrum of issues that are mission-critical to this important audience, enabling scientific research teams to gain scientific insights, increase productivity, elevate data quality, reduce lab process cycle times and enable experimentation that otherwise would be impossible.

Specifically, JALA explores ways in which scientists adapt advancements in technology for scientific exploration and experimentation. In direct relation to this, JBS reports how scientists use adapted technology to pursue new therapeutics for unmet medical needs, including assay development, identification of chemical probes and target identification and validation in general.